Scarica l'app Stockscreener
6.16
1.15%
0.07
Dopo l'orario di chiusura:
6.28
0.12
+1.95%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Precedente Chiudi:
$6.09
Aprire:
$6.17
Volume 24 ore:
3.02M
Relative Volume:
3.27
Capitalizzazione di mercato:
$254.20M
Reddito:
$134.48M
Utile/perdita netta:
$-38.94M
Rapporto P/E:
-6.4611
EPS:
-0.9534
Flusso di cassa netto:
$-19.34M
1 W Prestazione:
-1.60%
1M Prestazione:
-17.65%
6M Prestazione:
-31.48%
1 anno Prestazione:
-75.60%
Intervallo 1D:
$5.90
$6.33
Intervallo di 1 settimana:
$5.90
$6.78
Portata 52W:
$5.90
$26.38
Rxsight Inc Stock (RXST) Company Profile
Nome
Rxsight Inc
Settore
Industria
Telefono
949-521-7822
Indirizzo
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
6.16 | 251.31M | 134.48M | -38.94M | -19.34M | -0.9534 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-30 | Iniziato | William Blair | Mkt Perform |
| 2025-07-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Downgrade | Jefferies | Buy → Hold |
| 2025-07-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Iniziato | Piper Sandler | Neutral |
| 2025-04-09 | Downgrade | UBS | Buy → Neutral |
| 2025-04-04 | Downgrade | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-12-20 | Downgrade | Stifel | Buy → Hold |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-10-29 | Iniziato | Jefferies | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-08-06 | Reiterato | Needham | Buy |
| 2024-05-07 | Reiterato | BTIG Research | Buy |
| 2023-12-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Iniziato | Morgan Stanley | Overweight |
| 2023-04-13 | Iniziato | Oppenheimer | Outperform |
| 2022-12-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Iniziato | Needham | Buy |
Mostra tutto
Rxsight Inc Borsa (RXST) Ultime notizie
Aug Volume: What is RxSight Incs revenue forecast2026 Risk Factors & Accurate Technical Buy Alerts - baoquankhu1.vn
Vanguard realignment: RXST filings show 0 shares; subsidiaries report separately (RXST) - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Retail Trends: Is RxSight Inc a top pick in the sector2026 Price Targets & Low Drawdown Momentum Ideas - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight, Inc.(NasdaqGM:RXST) dropped from S&P Healthcare Equipment Select Industry Index - marketscreener.com
Volume Recap: What is RxSight Incs valuation compared to sectorQuarterly Profit Summary & Reliable Breakout Forecasts - baoquankhu1.vn
How The RxSight (RXST) Investment Story Is Shifting With New Guidance And CFO Transition - Yahoo Finance
How Rxsight Inc. (RXST) Affects Rotational Strategy Timing - news.stocktradersdaily.com
RxSight (NASDAQ: RXST) details CFO sign-on bonus and corrects option vesting - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - ACCESS Newswire
Breakout Watch: What is RxSight Incs revenue forecast2026 Opening Moves & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Aug Intraday: What is RxSight Incs revenue forecast2026 Biggest Moves & Entry Point Strategy Guides - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
RXST Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Tech Rally: Is CNTY affected by consumer sentiment2026 Geopolitical Influence & Advanced Technical Signal Analysis - baoquankhu1.vn
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
US Stocks Recap: What are the risks of holding RF Acquisition Corp IIPortfolio Performance Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Meridiem Capital Partners LP Buys New Position in RxSight, Inc. $RXST - MarketBeat
RxSight Inc Stock (ISIN: US78419L1008) Faces Analyst Pressure After Q4 Revenue Drop - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and RxSight (RXST) - The Globe and Mail
(RXST) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Stifel cuts RxSight stock price target to $9 on revenue guidance - Investing.com South Africa
Stifel Lowers Price Target for RxSight (RXST) Following Recent A - GuruFocus
Stifel Nicolaus Has Lowered Expectations for RxSight (NASDAQ:RXST) Stock Price - MarketBeat
RxSight Inc. (RXST) PT Lowered to $9 at Stifel After Prudent Guidance - StreetInsider
RxSight Earnings Call: Strong Core, Cautious Outlook - The Globe and Mail
RxSight downgraded at UBS after Q1 miss and guidance cut - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Silence Therapeutics (SLN), RxSight (RXST) and Compass Therapeutics (CMPX) - The Globe and Mail
Wells Fargo Upgrades RxSight (RXST) - MSN
How The RxSight (RXST) Investment Story Is Shifting With New Guidance And CFO Change - Yahoo Finance
RxSight announces executive leadership reorganization and new appointments - MSN
Midday Stock Roundup: Staar Falls 3.8% After Q4 Miss - Orange County Business Journal
Forecast Cut: Will RxSight Inc stock go up in YEARJuly 2025 Outlook & High Return Stock Watch Alerts - baoquankhu1.vn
RxSight (RXST) Q4 2025 Earnings Call Transcript - AOL.com
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight (RXST) CCO gains 6,261 shares, withholds 2,580 for taxes - Stock Titan
2026-03-03 | RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:RXST | Press Release - Stockhouse
RXST Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Short Interest in RxSight, Inc. (NASDAQ:RXST) Expands By 29.3% - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
2026-03-01 | Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation | NDAQ:RXST | Press Release - Stockhouse
Artisan Partners Limited Partnership Cuts Position in RxSight, Inc. $RXST - MarketBeat
RXST Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
RxSight, Inc. (RXST) Investor Outlook: Exploring a 28% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
RxSight, Inc. (NASDAQ:RXST) Q4 2025 Earnings Call Transcript - Insider Monkey
RXSTRxsight, Inc. Latest Stock News & Market Updates - Stock Titan
RxSight Reports Fourth Quarter and Fiscal Year Financial Results - VisionMonday.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect - ACCESS Newswire
Rxsight Inc Azioni (RXST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Rxsight Inc Azioni (RXST) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Weinberg Eric | See remarks |
Jun 02 '25 |
Option Exercise |
3.93 |
188,002 |
738,848 |
195,351 |
| Thunen Shelley B | See remarks |
Apr 14 '25 |
Option Exercise |
4.34 |
7,792 |
33,806 |
38,354 |
2.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):